Investment in NexGelRx (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 11, 2025 |
Dec. 31, 2025 |
|
| InvestmentsLineItems [Line Items] | ||
| Other Assets | $ 249 | |
| Warrant issued | 125,000 | |
| Warrant exercise price | $ 4.00 | |
| Warrant description | The warrants represent approximately 10% warrant coverage relative to the Investee’s capital raise and were classified as equity under ASC 815-40. The warrants were valued at $87 thousand using the Black-Scholes option model | |
| Warrant issued, value | $ 87 | |
| Nexgel RX [Member] | ||
| InvestmentsLineItems [Line Items] | ||
| Minority interest amount | $ 8,000 | |
| Proceeds from investments | $ 1,250 | |
| Nexgel RX [Member] | ||
| InvestmentsLineItems [Line Items] | ||
| Minority interest ownership percentage | 19.99% |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of reason for issuing warrant or right. No definition available.
|
| X | ||||||||||
- Definition The amount of noncontrolling interest in subsidiary represented by preferred securities issued by the subsidiary. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Amount of assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|